Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regulatory T-cell enumeration and function in psoriasis patients before and after conventional therapies
2010-019129-32Phase 4Terminated
- Sponsor
- University of Aberdeen
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of calcipotriol, betamethasone, acitretin, etanercept, adalimumab and 1 more in psoriasis (6 arms), sponsored by University of Aberdeen. Primary endpoints: Clinical response to therapy by PASI score and Correlation of regulatory T cells with clinical outcome. Started Mar 2010; status: terminated.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2010-019129-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019129-32.